Heterogeneity of primary site biopsies in head and neck squamous cell carcinoma

Anticancer Research

Volumn 31, Issue 2, 2011, Pages 665-669

  Moertel, Susanne ^a   Ackermann, Hanns ^a   Baghi, Mehran ^a   Eckardt, Anne ^a   Wagenblast, Jens ^a   Stöver, Timo ^a   Hambek, Markus ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

EGFR; Head and neck cancer; Ki 67; Squamous cell carcinoma; Translational research

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN;

ADULT; ARTICLE; CANCER LOCALIZATION; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORE NEEDLE BIOPSY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; FEMALE; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MALE; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SUPERFICIAL BIOPSY; TISSUE SECTION; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 79953236748     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Seiwert TY, Salama JK and Vokes EE: The chemoradiation paradigm in head and neck cancer. Nat Clin Pract Oncol 4: 156-171, 2007.
2. Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, Fu KK and Milas L: Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 62: 7350-7356, 2002 (Pubitemid 36025259)
3. Burtness B: Cetuximab and cisplatin for chemotherapy-refractory squamous cell cancer of the head and neck. J Clin Oncol 23: 5440-5442, 2005.
4. Kumar B, Cordell KG, Lee JS, Worden FP, Prince ME, Tran HH, Wolf GT, Urba SG, Chepeha DB, Teknos TN, Eisbruch A, Tsien CI, Taylor JM, D'Silva NJ, Yang K, Kurnit DM, Bauer JA, Bradford CR and Carey TE: EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 26: 3128-3137, 2008.
5. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK and Ang KK: Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck. N Engl J Med 354: 567-578, 2006. (Pubitemid 43209104)
6. Bernier J, Bonner J, Vermorken JB, Bensadoun RJ, Dummer R, Giralt J, Kornek G, Hartley A, Mesia R, Robert C, Segaert S and Ang KK: Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Ann Oncol 19: 142-149, 2008.
7. Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S, Erfan J, Zabolotnyy D, Kienzer HR, Cupissol D, Peyrade F, Benasso M, Vynnychenko I, De Raucourt D, Bokemeyer C, Schueler A, Amellal N and Hitt R: Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359: 1116-1127, 2008.
8. Jacob R, Welkoborsky HJ, Mann WJ, Hofken F, Dienes HP and Freije JE: Heterogeneity of squamous cell carcinomas of the head and neck-analysis of tumor biologic factors and proliferation rates. Laryngoscope 106: 1170-1175, 1996. (Pubitemid 26304611)
9. Takes RP, Baatenburg de Jong RJ, Keuning J, Hermans J, Schuuring E and Van Krieken HJ: Protein expression of cancer associated genes: biopsy material compared to resection material in laryngeal cancer. Anticancer Res 18: 4787-4791, 1998. (Pubitemid 29042061)
10. Chen B, van den Brekel MW, Buschers W, Balm AJ and van Velthuysen ML: Validation of tissue array technology in head and neck squamous cell carcinoma. Head Neck 25: 922-930, 2003. (Pubitemid 37323007)
11. Fritschy JM: Is my antibody-staining specific? How to deal with pitfalls of immunohistochemistry. Eur J Neurosci 28: 2365-2370, 2008.
12. van den Brekel MW, Bindels EM and Balm AJ: Prognostic factors in head and neck cancer. Eur J Cancer 38: 1041-1043, 2002. (Pubitemid 34468007)
13. Smith BD, Smith GL, Carter D, DiGiovanna MP, Kasowitz KM, Sasaki CT and Haffty BG: Molecular marker expression in oral and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 127: 780-785, 2001. (Pubitemid 32619354)
14. Grabenbauer GG, Muhlfriedel C, Rodel F, Niedobitek G, Hornung J, Rodel C, Martus P, Iro H, Kirchner T, Steininger H, Sauer R, Weidenbecher M and Distel L: Squamous cell carcinoma of the oropharynx: Ki-67 and p53 can identify patients at high risk for local recurrence after surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys 48: 1041-1050, 2000.
15. Licitra L, Rolland F, Bokemeyer C, Remenar E, Kienzer H, Stoerkel S, Scheid S, Stroh C and Mesia R: Biomarker potential of EGFR gene copy number by FISH in the phase III EXTREME study: Platinum-based CT plus cetuximab in first-line R/M SCCHN. J Clin Oncol (Meeting Abstracts) 27(suppl; abstr 6005): 15s, 2009.
16. Modjtahedi H and Essapen S: Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities. Anticancer Drugs 20: 851-855, 2009.